Jennifer M Brannan et al.
Cancer prevention research (Philadelphia, Pa.), 2(12), 1039-1049 (2009-11-26)
Overexpression of the receptor tyrosine kinase EphA2 occurs in non-small cell lung cancer (NSCLC) and a number of other human cancers. This overexpression correlates with a poor prognosis, smoking, and the presence of Kirsten rat sarcoma (K-Ras) mutations in NSCLC.